Stimulation with anti-Cenp-B+ and anti-Topo-I+ sera increased ACTA2, COL1A1, and TAGLN expressions compared to control sera and to SSc Cenp-B−/Topo-I− sera for all the fibroblast populations. Here, COL1A1 is linked to systemic sclerosis.